Testing the Effect of KnowMAP (Knowledge Management for Renal Transplant Recipients). A Randomized Controlled Study

Kidney Transplantation Clinical Trial

— KnowMAP  

Official title:

Testing the Effect of a New Health Communication Intervention for Renal Transplant Recipients (KnowMAP).

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04296955
• Other study ID #: 29385
• Status: Active, not recruiting
• Phase: N/A
• Start date: March 9, 2020
• Est. completion date: October 31, 2025

Study information

• Verified date: October 2023
• Source: Oslo University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A randomized controlled study (RCT) aiming to test the effect of a new health literacy intervention for renal transplant recipients, KnowMAP (knowledge management for renal transplant recipients).

Description:

Every year about 250-300 kidney transplantations are performed at Oslo University Hospital in Norway. Considerable improvements have recently emerged within kidney transplantation in relation to survival and quality of life. However, after transplantation, adherence to immunosuppressive drug therapy and other medical advices is crucial for staying healthy, keeping the graft, and retain good quality of life. In case of graft loss the patient has to return to dialysis, representing reduced functioning, fatigue and negative impact on quality of life. Dialysis also leads to higher costs for the society and in many cases a need for re-transplantation. A key challenge to adherence is the ability to gain access to, understand and use health information, defined as health literacy by the WHO. For renal transplant recipients preparedness for handling information and going through transplantation is essential. Hence, supporting the patients becoming reflective and health literate knowledge users is crucial. Through a RCT this project aims to test the effect of a new health communication intervention, KnowMAP (knowledge management for renal transplant recipients), as compared with standard care in patients undergoing renal transplantation. KnowMap is a novel intervention designed by clinicians and researchers at Oslo University Hospital (OUS), University of Oslo (UiO) and University of Stavanger (UiS). The intervention is targeting knowledge management skills of patients by using motivational interview (MI) techniques. It represents 4 sessions of individual patient counselling starting the first week after the transplantation.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 200
• Est. completion date: October 31, 2025
• Est. primary completion date: June 15, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Kidney transplanted patients > 18 years included within few days after kidney transplantation at Oslo University Hospital
• Able to speak and understand Norwegian

Exclusion Criteria:

• Not able to speak or understand Norwegian well enough to be able to fill out forms or have a conversation in Norwegian.
• Kidney transplanted patient <18 years

Related Conditions & MeSH terms

• Kidney Transplantation

Intervention

Other:
• Motivational interview as a new health communication intervention
Same as intervention name

Locations

Country	Name	City	State
Norway	Oslo University Hospital	Oslo

Sponsors (2)

Lead Sponsor	Collaborator
Oslo University Hospital	Helse Sor-Ost

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health literacy (HL)	HL measured by the HLQ (Health Literacy Questionnaire): The HLQ includes 44 items over nine independent scales, each representing a different element of the overall HL construct. Each scale includes 4-6 items. The first five scales comprise items asking the respondents to indicate level of agreement [ranging from strongly disagree to strongly agree (range 1-4)]. The remaining scales (6-9) have domains of self-reported capability (range 1-5: 'cannot do' to 'very easy'). The questionnaire has no total score, as that could potentially mask individual needs in specific HL domains. The HLQ appears robust for its intended purpose of assessing HL in a range of settings and has shown excellent reliability.	24 months post transplantation
Primary	Adherence to immunosuppressive medication	The instrument BAASIS (The BAsel Adherence to immunoSuppressIve medication Scale) a self reporting adherence questionnaire measuring patients' taking, skipping, timing (>2 hrs from prescribed time) and dose reduction of drugs. The recall period is limited to four weeks. The BAASIS comprises four questions with a 6-point scale for responses ranging from never (0) to every day (5)	24 months post transplantation
Secondary	Quality of life and cost-effectiveness estimates relevant to this clinical context	using EQ-5D-5L, introduced by EuroQoL in 2009. It is a two pages, standardized generic questionnaire.	24 months post transplantation
Secondary	Knowledge	Using a Norwegian developed questionnaire: "The Transplantation Knowledge Questionnaire"	24 months post transplantation
Secondary	Occations of graft loss	Registred in the Norwegian Renal Registry (NNR)	24 months post transplantation